Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 134Carcinoma, Renal Cell 51Kidney Neoplasms 42Leukemia, Myeloid, Acute 38Neoplasm Metastasis 37Leukemia 33Lymphoma 30Breast Neoplasms 26Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 22Carcinoma, Non-Small-Cell Lung 22Skin Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Neuroblastoma 18Lymphoma, Follicular 18Pancreatic Neoplasms 16Lymphoma, Mantle-Cell 16Leukemia, Lymphocytic, Chronic, B-Cell 16Stomach Neoplasms 14Neoplasms 14Myelodysplastic Syndromes 14Colorectal Neoplasms 13Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Hodgkin Disease 12Congenital Abnormalities 12Uterine Cervical Neoplasms 11Lymphoma, Large-Cell, Immunoblastic 11Lung Neoplasms 11

Interventions

fludarabine phosphate 2aldesleukin 2Cyclophosphamide 2fludarabine 1Whole-Body Irradiation 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Melanoma, Experimental × aldesleukin × Clear all
NCT00513604 2013-06-03

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
158 enrolled 14 charts
Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms, Skin Neoplasms

NCT00924001 2012-10-25

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
1 enrolled 8 charts
Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡